Franklin Genomic Advancements ETF (HELX) |
| 37.283 0 (0%) 01-14 09:47 |
| Open: | 37 |
| High: | 37.34 |
| Low: | 37 |
| Volume: | 170 |
| Market Cap: | 19(M) |
| PE Ratio: | 33.13 |
| Exchange: | Chicago Board Options Exchange |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 44.58 |
| Resistance 1: | 38.17 |
| Pivot price: | 37.09 |
| Support 1: | 36.81 |
| Support 2: | 35.97 |
| 52w High: | 38.17 |
| 52w Low: | 23.74 |
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 06 Jan 2026
(HELX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Fri, 26 Dec 2025
Understanding the Setup: (HELX) and Scalable Risk - Stock Traders Daily
Tue, 25 Nov 2025
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - Yahoo Finance
Fri, 21 Nov 2025
Inside the Recent Strength in Biotech ETFs - Zacks Investment Research
Mon, 06 Nov 2023
Contact Us - Concord Monitor - Franklin Templeton Launches Franklin Focused Growth ETF (FFOG) - FinancialContent
Thu, 14 Jan 2021
Franklin Templeton Launches Active ETF, 'XDAT' - ETF Database
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
